The Health Technology Assessment (HTA) Regulation aims to enhance the availability of innovative health technologies, such as medicines and certain medical devices, for patients across the European Union (EU). Additionally, it seeks to ensure the efficient use of resources and strengthen the quality of HTA throughout the Union. HTA provides comprehensive information on the clinical, economic, social, and ethical aspects of health technology usage, aiding Member States in making evidence-based decisions. This ensures healthcare remains accessible, sustainable, and of high quality.

In this forum, we will review the current status of the regulation’s implementation and provide a detailed explanation of the European regulation. Join us to explore the progress and challenges faced by individual Member States and understand how these regulations are shaping healthcare delivery across the EU.